Flexion Therapeutics' (FLXN) FX006 Granted FDA Fast-Track Designation

September 1, 2015 4:03 PM

Flexion Therapeutics (NASDAQ: FLXN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for FX006 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found